Activating a new mechanism to promote cell death could provide hope for better mesothelioma treatments, a Japanese study indicates. The research, ”Connexin 43 enhances Bax…

Combining immunotherapy, accelerated radiation and surgery can improve immune system response against malignant pleural mesothelioma, according to a study. Immunotherapies for solid tumors have become a…

A study that looked into France’s RENAPE Observational Registry, a database of rare peritoneal tumors, found that the presence of programmed death-ligand 1 (PD-L1) on…

It is safe for malignant mesothelioma patients to combine Tremelimumab and Imfinzi (durvalumab), according to a study to be presented at the 2017 American Society of Clinical…

A new study reports that a protein formerly identified as a potential therapeutic target in pleural mesothelioma, CXCR4, might not be a relevant approach for the…

Researchers found that a protein with anti-cancer activity, which is isolated from the bullfrog, may be a good treatment option for mesothelioma, including in standard-of-care…

Even though 40 years have passed since their exposure to asbestos, workers’ risk of developing mesothelioma continues to rise, new research shows. Individuals exposed to asbestos four decades ago…

The more mesothelioma tumor cells that express the mesothelin protein, the longer a patient is likely to live, according to a study. That finding is…